Figure 1From: Complications after oesophagectomy with possible contribution of neoadjuvant therapy including an EGFR-antibody to a fatal outcomeSevere acute generalized exanthematic pustulosis (AGEP) five weeks after first cycle of cetuximab therapy.Back to article page